Vina Churdboonchart
Corporate Officer/Principal chez Mahidol University
Profil
Dr. Vina Churdboonchart is President at Trinity Medical Group, Inc. and a Member at Mahidol University.
Postes actifs de Vina Churdboonchart
| Sociétés | Poste | Début |
|---|---|---|
| Mahidol University | Corporate Officer/Principal | 25/02/2010 |
Anciens postes connus de Vina Churdboonchart
| Sociétés | Poste | Fin |
|---|---|---|
Trinity Medical Group, Inc.
 Trinity Medical Group, Inc. Miscellaneous Commercial ServicesCommercial Services Trinity Medical Group, Inc. markets HIV-Immunogen also known as REMUNE, a patented therapeutic vaccine treatment, designed to induce specific T cell responses in people infected with the Human Immunodeficiency Virus. REMUNE is an immune-based therapy consisting of whole inactivated HIV-1 virus depleted of its gp120 coat protein based on Dr. Jonas Salk's vaccine technology. The company was founded on September 28, 1998 and is headquartered in Las Vegas, NV. | Fondateur | 25/02/2010 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Trinity Medical Group, Inc.
Trinity Medical Group, Inc. Miscellaneous Commercial ServicesCommercial Services Trinity Medical Group, Inc. markets HIV-Immunogen also known as REMUNE, a patented therapeutic vaccine treatment, designed to induce specific T cell responses in people infected with the Human Immunodeficiency Virus. REMUNE is an immune-based therapy consisting of whole inactivated HIV-1 virus depleted of its gp120 coat protein based on Dr. Jonas Salk's vaccine technology. The company was founded on September 28, 1998 and is headquartered in Las Vegas, NV. | Commercial Services |
